Australasian Science: Australia's authority on science since 1938

Window of Opportunity

Interleukin-2 therapy will achieve a complete response when it is administered d

Interleukin-2 therapy will achieve a complete response when it is administered during a 12-hour window in the 7-day immune cycle.

By Martin Ashdown & Brendon Coventry

By targeting cancer treatments to specific phases of the immune cycle, researchers believe they can dramatically improve the chances of complete remission.

To view this article subscribe or purchase a yearly pass here.